Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy

I. Ivancsó, N. Eszes, G. Beko, A. Bohács, G. Toldi, J. Rigó, Jr., G. Losonczy, B. Vásárhelyi, L. Tamási (Budapest, Hungary)

Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session: Diagnosis and management of respiratory diseases
Session type: Thematic Poster Session
Number: 4166
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Asthma has a high burden of morbidity if not controlled and frequently complicates pregnancy posing a risk for complications. Serum hyaluronic acid (HA) is an acknowledged marker of tissue fibrosis which promotes eosinophil survival and plays a role in airway remodeling. Although circulating HA is easily measurable, and its role is supposed in asthmatic inflammation, tissue remodelling and maintenance of normal pregnancy as well, to date there are no data on its levels in asthmatic pregnancy. The possible relationship of circulating HA levels and clinical asthma control is also unknown.
The aim of this study was to evaluate the serum levels of HA in asthmatic pregnant (AP; N=17) and asthmatic non-pregnant (ANP; N=42) patients. The possible relationship between HA levels and asthma control determinants (spirometry, symptoms) was also evaluated.
Serum HA level was lower in AP than in ANP patients (27 [24.8-36.4] vs. 36.3 [27.35-52.60] ng/mL, p=0.026). A positive correlation was found between HA and airway resistance in ANP (r=0.3684, p=0.019) but not in AP patients. ROC analysis of HA values in asthmatic patients with Asthma Control Test total score above and below 20 yielded an AUC of 0.74 (95% CI: 0.58-0.90, p=0.015) and identified an optimal cut-off value of 25.8 ng/mL between controlled and not controlled asthmatic patients.
Serum HA might be a marker of asthma control, since it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control. Lower circulating HA level detected in pregnant than in non-pregnant asthmatics may be the consequence of pregnancy induced immune tolerance and attenuated systemic inflammatory responses.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Ivancsó, N. Eszes, G. Beko, A. Bohács, G. Toldi, J. Rigó, Jr., G. Losonczy, B. Vásárhelyi, L. Tamási (Budapest, Hungary). Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy. Eur Respir J 2013; 42: Suppl. 57, 4166

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessment of serum magnesium level in patients with bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Fatty acid blood spectrum in patients with asthma
Source: International Congress 2016 – Asthma points to ponder
Year: 2016

Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015

Free serum IL-18 levels and responsiveness to omalizumab in patients with severe asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016

YKL-40 levels in cord blood – Associations with respiratory symptoms and asthma in children?
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015


Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016

Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015


Serum periostin but not airway POSTN expression is reduced in smokers with asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013

Relation of plasma osteopontin levels with the clinical course in patients with COPD
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015


Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015

A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013